X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

GOVX

Closed

Geovax Labs Inc

0.485
-0.381 (-44.01%)
Last Update: 01 Jul 2025 23:28:00
Yesterday: 0.8657
Day's Range: 0.43 - 0.5811
Send
When Written:
 
0.69
GeoVax Labs Inc. is a clinical-stage biotechnology company that focuses on developing vaccines against infectious diseases and cancer. The company's technology platform is based on a modified vaccinia Ankara (MVA) virus that can be engineered to express antigens from various pathogens, including HIV, Zika virus, and Ebola virus. GeoVax's lead product candidate is a preventive HIV vaccine that is currently in Phase 2a clinical trials. The company is also developing therapeutic vaccines for HIV and cancer. GeoVax is headquartered in Atlanta, Georgia, and was founded in 2001.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X